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Foot-and-mouth disease virus (FMDV), a positive sense, sin-
gle-stranded RNA virus, causes a highly contagious disease in
cloven-hoofed livestock. Like other picornaviruses, FMDVhas a
conserved 2C protein assigned to the superfamily 3 helicases, a
group of AAAATPases that has a predicted N-terminal mem-
brane-binding amphipathic helix attached to the main ATPase
domain. In infected cells, 2C is involved in the formation of
membrane vesicles, where it co-localizes with viral RNA repli-
cation complexes, but its precise role in virus replication has not
been elucidated. We show here that deletion of the predicted
N-terminal amphipathic helix enables overexpression in Esche-
richia coli of a highly soluble truncated protein, 2C(34–318),
that has ATPase and RNA binding activity. ATPase activity was
abrogated by point mutations in the Walker A (K116A) and B
(D160A)motifs andMotif C (N207A) in the active site. Unligan-
ded 2C(34–318) exhibits concentration-dependent self-associ-
ation to yield oligomeric forms, the largest of which is tet-
rameric. Strikingly, in the presence of ATP and RNA, FMDV
2C(34–318) containing the N207A mutation, which binds but
does not hydrolyze ATP, was found to oligomerize specifically
into hexamers. Visualization of FMDV 2C-ATP-RNA com-
plexes by negative stain electron microscopy revealed hexameric
ring structures with 6-fold symmetry that are characteristic of
AAA ATPases. ATPase assays performed by mixing purified
active and inactive 2C(34–318) subunits revealed a coordinated
mechanism of ATP hydrolysis. Our results provide new insights
into the structure andmechanismof picornavirus 2Cproteins that
will facilitate new investigations of their roles in infection.
Foot-and-mouth disease virus (FMDV)5 causes a highly con-
tagious disease of cloven-hoofed animals, such as cattle, sheep,
and pigs (1, 2). As amember of the picornavirus family that also
includes human pathogens, such as poliovirus (PV), hepatitis A
virus (HAV), and human rhinovirus, FMDV possesses a single-
stranded, positive sense RNA genome of some 8500 nucleo-
tides, containing one large open reading frame. This is trans-
lated as a single polyprotein that is co- and post-translationally
cleaved by viral proteases to release themature proteins needed
for virus replication (1).
Following the initial rounds of translation, the RNA genome
is used as the template for the synthesis of a complementary
negative strand that, in turn, becomes the template for the syn-
thesis of many positive strands. This asymmetric replication
process generates genomic copies that are packaged to make
new virions (1). Picornavirus infection causes rearrangement of
intracellular membranes into characteristic vesicles that pro-
vide platforms for assembly of the viral RNA replication com-
plex, which largely comprises mature and precursor proteins
derived from the P2 and P3 regions of the polyprotein (3–5).
Targeting of replication complexes to vesicularmembranes has
a number of potential benefits, such as increasing the local con-
centration of the viral and cellular proteins co-opted for RNA
synthesis or shielding the viral RNA from cellular sensors of
infection (6). Rearrangement of intracellular membranes dur-
ing FMDV and PV infection is accompanied by the disruption
of normal cellular protein trafficking and cell surface presenta-
tion of viral peptides or release of cytokines; both of these
effects may dampen the antiviral response of the host (7–10).
Several of the picornavirus proteins involved in RNA repli-
cation (2B, 2C, and 3A) have membrane binding properties,
although their precise roles in replication have yet to be fully
worked out. Although they are implicated in disturbing the
structure and/or function of membranes in host cells, their
effects show some variations between different picornaviruses
(3, 9, 11, 12). For PV, transient expression of 2C or 2BC in
mammalian cells induces vesicular clustering, similar to the
membrane rearrangements observed during infection (11);
however, PV 2B, 2BC, or 3A (but not 2C) are each capable of
disrupting protein trafficking and cell surface protein expres-
sion, with 3A being the most efficient blocker (9, 13). In con-
trast, the vesicles observed during FMDV infection do not clus-
ter (5, 12). The particular FMDV proteins responsible for
vesicularization have not been identified, although it has been
shown that transient expression of 2B and 2C or of the 2BC
precursor (but not 3A) is sufficient to impede trafficking of pro-
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teins between the endoplasmic reticulum and Golgi and their
expression on the cell surface (7, 12).
2C is the largest and arguably the most complex of the mem-
brane-binding components of the virus RNA replication com-
plex. FMDV 2C, a 318-amino acid polypeptide, exemplifies the
common architecture of picornavirus 2C proteins. It has a pre-
dicted amphipathic helix in its N terminus (residues 17–34)
(14), a feature that has been shown for other picornaviruses to
confer the ability to bind to cell membranes (15–18) and is
thought to be required for both membrane rearrangement and
formation of the viral replication complex (3). This predicted
helix lies upstream of a well conserved ATPase domain (19)
formed by residues 60–270. However, FMDV 2C is unusual in
lacking a Cys-rich motif at its C terminus that, although con-
served in several other 2C proteins, is of unknown function
(20).
The ATPase domains of picornavirus 2C proteins contain
Walker A andWalker B motifs characteristic of many enzymes
that hydrolyze NTPs (19, 21, 22) (Fig. 1a). The detection of a
thirdmotif,Motif C, resulted in 2Cbeing classified as anAAA
(ATPases associated with various cellular activities) protein
subgrouped with superfamily 3 (SF3) helicases, such as the
SV40 largeT-antigen (LTag) and bovine papillomavirus E1 (E1)
DNAhelicases (19). This designation implies that 2Cmay act as
an RNA helicase, but, although the enzyme is capable of hydro-
lyzing nucleotides (23–26) and binds RNA (see below), no heli-
case activity has yet been reported for the 2C protein of any
picornavirus. In the case of PV, the ATPase activity appears not
to be necessary for the induction of membrane rearrangements
by 2C (22); nevertheless, this activity is clearly important for
virus infection because mutations of theWalker A orWalker B
motifs that block ATP hydrolysis by PV 2C (23) also prevent
virus replication (21, 22).
The replication of several picornaviruses is also inhibited by
low (2–3 mM) concentrations of guanidine hydrochloride
(GdnHCl), an effect that is generally attributable to drug inter-
actions with the 2C protein because mutations in 2C confer
resistance on the virus (27–31). Such mutations include an
M159L substitution in the Walker B motif of FMDV 2C (29)
and a N179A mutation within the ATPase active site of PV 2C
(27). In vitro studies confirm that 2C is the target of GdnHCl for
PV and suggest that the drug works by interfering with the
ability of the protein to hydrolyze ATP. The ATPase activity of
purified recombinant PV 2C containing the N179A mutation
was 100-fold higher than the wild-type protein in the presence
of 1 mM drug (23). However, not all picornavirus 2C proteins
are so sensitive to the drug; for example, 2C from echovirus-9
(EV9) was only very weakly inhibited by GdnHCl even at con-
centrations as high as 20 mM (28).
Consistent with the predicted helicase role of 2C, the protein
also binds RNA. PV 2C was readily cross-linked to replicating
viral RNA by exposure of infected cells to UV light (3). How-
ever, the specificity of RNA binding by 2C is still unclear. A
significant problem in the investigation of the RNA binding,
which also impacts the study of other 2C activities, is the gen-
erally poor solubility of the recombinant protein. His6-tagged
2C proteins from PV, HAV, and human rhinovirus, which had
to be denatured and refolded during purification from inclu-
sion bodies, were reported to bind a specific sequence in the 3
negative strand viral RNA (32, 33). In contrast, following puri-
fication under non-denaturing conditions, PV 2C fused to mal-
tose-binding protein (MBP-2C) andHis6-tagged versions of 2C
from HAV and EV9 were all found to interact nonspecifically
with RNA (17, 24, 34). It is notable that in experiments done
with His-tagged proteins from HAV and EV9, the 2C-RNA
complexes formed aggregates that were unable to enter poly-
acrylamide gels during mobility shift assays (17, 34).
In commonwith other AAA proteins, SF3 helicases appear
to oligomerize into hexamers to form a functional unit (35–37),
although the ability of these proteins to assemble into heptam-
ers in the absence of substrates has also been reported (38).
Crystallographic analysis of the LTag and E1 helicases, for
example, revealed a ring structure formed from six subunits
(39–41). TheATPase active sites of these hexamers are formed
at the interfaces between pairs of subunits. In the active sites,
one subunit provides theWalker A and Bmotifs (42) andMotif
C (19) (sensor 1 inAAA nomenclature (35)), whereas an adja-
cent subunit contributes an arginine residue (the “R finger”)
that interacts with the triphosphate tail during catalysis. Con-
sistent with this architecture, the ATPase activity of these pro-
teins is dependent on oligomerization (36). The structure of
BPV E1 co-crystallized with ATP, and a short length of single-
stranded DNA showed that the oligonucleotide was threaded
through the pore formed at the center of the hexameric protein
andmakes differential contactswith each subunit that suggest a
plausible helicase mechanism (39).
Is hexamerization also necessary to activate ATPase hydro-
lysis and other functions attributed to picornavirus 2C pro-
teins? An interesting recent study showed that the MBP-2C
fusion protein prepared from PV 2C formed homo-oligomers
that were necessary for the ATPase activity of the protein (43),
consistent with some earlier work (27, 44, 45). Moreover, the
study found that deletion of the N-terminal 38 residues of the
2C portion of the fusion protein, which removes the predicted
amphipathic region involved in membrane binding, abrogated
both the oligomerization and ATPase activity of this MBP-2C
construct (43). Curiously, analysis by size exclusion chromatog-
raphy and electron microscopy revealed that the MBP-2C pro-
tein formed oligomeric species that ranged from tetramers to
octamers. It is currently not clear why this range of sizes is
much broader than found with other AAA and related pro-
teins, which are typically hexameric or heptameric (46–48).
To further the investigation of the assembly and enzymatic
properties of picornavirus 2C proteins, we aimed to engineer
recombinant FMDV 2C that could be produced as a soluble
protein in Escherichia coli without the encumbrance of a large
protein tag. We now show that overexpression of soluble
FMDV 2Cwith anN-terminal His tag can be achieved by delet-
ing the N terminus of the protein up to and including the pre-
dicted amphipathic helix. The FMDV 2C(34–318) construct
has been used in in vitro studies that complement ongoing
investigations of the effects of 2C in transfected mammalian
cells (7, 12). Following proteolytic removal of the His tag, the
resulting protein can be concentrated to at least 20 mg/ml, and
it exhibits specific ATPase activity and nonspecific RNA bind-
ing activity. In the absence of ligands, FMDV 2C(34–318)
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exhibits concentration-dependent oligomerization, the largest
form of which is tetrameric. However, in the presence of ATP
andRNA, amutant of 2C(34–318) that can bind but not hydro-
lyze the nucleotide specifically assembles, even at low concen-
trations, into a hexameric ring structure, demonstrating that
the N terminus of the protein is not required for oligomeriza-
tion. ATPase assays performed with mixtures of active and
inactive 2C subunits support the hypothesis that hexameriza-
tion is necessary for a coordinated mechanism of nucleotide
hydrolysis. We propose that assembly into hexameric rings is a
general requirement for the proper functioning of picornavirus
2C proteins.
EXPERIMENTAL PROCEDURES
Cloning—All PCR and mutagenesis primers used in this
study are listed in supplemental Table S1. A pCR-XL-TOPOplas-
mid containing the type O1K FMDV 2C sequence (GenBankTM
accession number X00871) (derived from a full-length infec-
tious cDNA) was used as template for the generation of FMDV
2C constructs. cDNAs for 2C(1–318), 2C(38–318), 2C(52–
318), and 2C(61–318) were amplified by PCR using primers
designed to incorporate an upstream BamHI site and a down-
stream HindIII site to facilitate ligation into a modified
pETM-11 plasmid (EMBL) to express the 2C product with a
TEVpro cleavable N-terminal His6 tag (49); because of an
internal NcoI site in the FMDV 2C sequence, the NcoI site in
pETM-11 was first changed to a BamHI site using the
QuikChange method (Stratagene). The pET-h2C(38–318)
construct was used as template in QuikChange reactions to
generate pET-h2C(34–318), which, in turn, served as the
template for introduction of point mutations by the same
method. Cloning and expression of GST-FMDV 2C is
described in the supplemental material. All expression plas-
mids were sequenced by MWG Eurofins Ltd.
Expression and Purification—Proteins were produced in
E. coli BL21 (DE3) pLysS cells. Cells for expression of His6-
tagged 2C constructs were grown at 37 °C to an A600 of 0.7.
Isopropyl -D-thiogalactopyranoside (0.5 mM) was added, and
cells were incubated with shaking for a further 4 h at 37 °C
before being harvested by centrifugation and stored at80 °C.
Pellets were resuspended in lysis buffer, containing 50 mM
HEPES, pH 7.1, 400 mM NaCl, 1 mM -mercaptoethanol 0.1%
(v/v) Triton X-100; cells were lysed by sonication. His6-tagged
protein was batch-purified on TALON (Clontech). The tag was
removed with His6-tagged TEVpro before the protein was
reverse purified over a second bed of TALON. The 2C protein
was further purified by gel filtration on a Superdex S200 10/30
column (GE Healthcare) in 50 mM HEPES, pH 7.1, 200 mM
NaCl, and 1mM-mercaptoethanol at a flow rate of 0.4ml/min.
Except where stated otherwise, the soluble 2C proteins
obtained were concentrated in the gel filtration buffer to 20
mg/ml and stored at80 °C.
ATPase Assays—ATP hydrolysis was measured with a color-
imetric assay based on the malachite green dye method
described previously (50, 51). ATPase assays were performed in
96-well plates in 100-l reaction volumes containing 50 mM
HEPES, pH 7.3, 1 mM dithiothreitol, 2 mM MgCl2 in the pres-
ence of 2C (typically 1.25M) and ATP (or another NTP) at the
concentrations indicated in the relevant figure legends. The
reactions were terminated by the addition of 200l of the color
reagent described by Mahuren et al. (51). The production of
phosphate was measured by the increase in absorbance at 590
nm read on a Sunrise 96 well microplate reader (Tecan).
ATP Binding Assays—UV cross-linking of ATP to FMDV 2C
was performed as described by Schumacher et al. (52). FMDV
2C (20 M) was incubated with 40 Ci of [-32P]ATP (3000
Ci/mmol) (PerkinElmer Life Sciences), in 25 mM HEPES, pH
7.1, 100 mM NaCl, 2 mM MgCl2, 0.5 mM -mercaptoethanol.
Samples (10l), spotted onto glass slides, were irradiated for 20
min over ice at 254 nm using a 6-watt UVG-54 lamp (UVP Inc.)
before analysis by SDS-PAGE. Protein bands were visualized
with Instant Blue protein stain (Expedeon) prior to gel drying.
Radiolabel was detected by exposure to a phosphor screen,
which was read on a Fuji FLA-5000 phosphor imager with
AIDA software (Raytest).
RNA Binding Assays—Synthetic RNA oligomers used in this
study were purchased from Dharmacon Ltd. RNA was radiola-
beled at the 5 terminus using [-32P]ATP and T4 polynucle-
otide kinase (Promega). RNA binding assays were performed
essentially as described previously (53) using 0.5 nM RNA and
final binding conditions of 50 mMHEPES, pH 7.1, 40 mMNaCl,
2mMMgCl2, 1mMdithiothreitol, and 2C(34–318) at 0–60M.
Samples were analyzed in 10% acrylamide gels using 50 mM
Tris, 50mM boric acid running buffer and autoradiographed on
a Fuji FLA-5000 phosphor imager.
Size Exclusion Chromatography-Multiangle Light Scattering
(SEC-MALS)—FMDV 2C samples were applied to a Superdex
200 10/30 column (GE Healthcare) pre-equilibrated in buffer
containing 50 mM HEPES, pH 7.3, 200 mM NaCl, 2 mM -mer-
captoethanol, 0.02% sodium azide. MgCl2 and ATP were
included in the running buffer as indicated throughout. The
buffer and sample were pumped through the column using a
Varian HPLC system (Varian, Inc.) coupled in line to a DAWN
Helios II light scatter detector (18 detectors) (Wyatt) andOpti-
lab rEXDifferential Refractive Index Detector (Wyatt) at a flow
rate of 0.5 ml/min. Peak analysis was performed using the
ASTRA software package (Wyatt).
Electron Microscopy—2 l of the 2C-ATP-RNA complex at
0.1 mg/ml was taken directly from a gel filtration experiment,
applied within 30 min to glow-discharged continuous carbon
grids (TAAB), and then stained with 2% uranyl acetate. Elec-
tron micrographs were taken on a Philips CM200 electron
microscope operating at 200 kV under low dose conditions of
10 e/Å2. Images were captured directly at 50,000 magni-
fication on a 4096 4096 pixel F415 CCD camera (Tietz Video
and Image Processing Systems), giving a pixel size of 1.76
Å/pixel. Image processing was performed using IMAGIC-5
software (54). Particles were picked manually, and the data
were coarsened by a factor of 2, giving a working pixel size of
3.52 Å/pixel. The final data set consisted of 1600 particles,
which were normalized and band pass-filtered between 10 and
150 Å. Individual images were translationally aligned to the
rotationally averaged total sum and analyzed by multivariate
statistical analysis (MSA), followed by classification to form
class averages containing20 particles/class. The eigenimages
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resulting from MSA can be used to assess the main symmetry
components present in the particle data set (55).
RESULTS
Expression of Soluble FMDV 2C—Previous studies of picor-
naviral 2C proteins have frequently involved the use of large
N-terminal fusion tags to overcome the poor solubility of native
2C (23, 24, 43, 56). In anticipation of similar problems with
FMDV 2C, we tried a number of different approaches to obtain
a soluble, active form of the protein that would facilitate struc-
tural and functional characterization. The various constructs
designed for production of FMDV 2C in E. coli are summarized
in Fig. 1a. First, following previous work on other picornavirus
2C proteins, we found that GST-FMDV 2C was strongly
expressed in E. coli (supplemental Fig. S1a). However, only a
very small fraction of the protein was recovered from the solu-
ble fraction in cell lysates, and that had suffered significant pro-
teolysis (supplemental Fig. S1b). The low molecular weight
contaminants present in the partially purified sample were
removed by gel filtration (supplemental Fig. S1c), but the
addition of thrombin to remove the GST tag resulted in cleav-
age of GST-FMDV 2C at a site internal to 2C, as shown by the
generation of a 50-kDa GST-2C cleavage product (supple-
mental Fig S1d).
The inability to process the GST-FMDV 2C fusion and the
poor yield of purified protein (0.5 mg from 8 liters of E. coli
culture) prompted us to seek alternative methods for obtaining
soluble protein. We next created pET-h2C(1–318), which was
designed to produce full-length FMDV 2C with an N-terminal
His6 tag that could be removed by TEVpro cleavage. However,
expression of this construct was toxic to E. coli because the
growth of the culture was arrested upon induction with isopro-
pyl -D-thiogalactopyranoside (Fig. 1b, dotted line). Modifica-
tion of this construct to introduce a K116Amutation that abro-
gates ATP hydrolysis by FMDV 2C (see below) did not relieve
the growth arrest due to the induction of protein expression in
E. coli (Fig. 1b, broken line), indicating that the observed toxic-
ity is not due to the ATPase activity of the protein.
To examine if the predicted N-terminal amphipathic region
of FMDV 2C was responsible for the growth arrest of E. coli
cultures, the hydrophobic residues of the putative amphipathic
helix (Trp18, Leu19, Val20, Leu22, Ile23, Leu24, Ile26, and Trp29)
were mutated to Ala. This mutation strategy successfully elim-
inated the toxicity of the protein and resulted in good expres-
sion of FMDV 2C (data not shown). Unfortunately, this helix
mutant was poorly soluble and precipitated at concentrations
over 0.5 mg/ml; it was therefore not used in any experiments.
Significantly, however, this observation suggested that the pre-
dicted amphipathic region of FMDV 2C is responsible for the
toxic effects of the protein inE. coli.We suspect that expression
of theGST-2C protein is permissible in E. coli because the large
GST tag may interfere with the membrane interactions of the
N-terminal amphipathic helix in FMDV 2C. Our findings are
also consistent with work on HAV 2C, which showed that par-
tial deletion of the predicted amphipathic region relieved the
toxicity of the protein in E. coli (17).
We therefore generated FMDV 2C deletion mutants lacking
the putative amphipathic helix (residues 17–34) (14). The
FIGURE1.Modificationsof theN terminusof FMDV2C toenhance soluble
overexpression inE. coli.a, schematic representationof themodified FMDV
2C proteins produced for this study. TheWalker A (WA), Walker B (WB), and C
(MC) motifs are indicated. Residues mutated in these motifs are underlined.
The predicted N-terminal amphipathic region is shaded gray; the black box
indicates the N-terminal His6 tag. b, E. coli growth curves following induction
ofHis6-taggedwild type2C(1–318) (broken line), theWalkerAmutant (K116A)
2C(1–318)WA (dotted line), or the deletionmutant 2C(34–318) (solid line); cell
density was monitored by OD measurements at 600 nm. c, size exclusion
chromatography of purified FMDV 2C(34–318) and 2C(61–318). In five sepa-
rate runs, 10mg (solid line), 7.5mg (dashed line), 5mg (dotted line), and 2.5mg
(dashed-single dotted line) of 2C(34–318) or 10 mg of 2C(61–318) (dashed-
double dotted line) was loaded onto the column. The elution positions of
molecular mass standards are indicated: 1) -amylase (200 kDa), 2) alcohol
dehydrogenase (150 kDa); 3) BSA (66 kDa), 4) carbonic anhydrase (29 kDa),
and 5) cytochrome c (12.5 kDa). d, 12% SDS-PAGE of the peak fractions from
the 10-mg run shown in c.
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design of constructs was guided by sequence alignments with
homologous AAA proteins of known structure, such as p97
(57) and BPV E1 (39), which indicated that the body of the
ATPase domain in FMDV2C starts at around residue 60. These
constructs included pET-h2C(34–318), pET-h2C(38–318),
pET-h2C(52–318), and pET-h2C(61–318) that produce pro-
teins with an N-terminal TEVpro-cleavable His6 tag, which lack
the first 33, 37, 51, and 60 residues of 2C, respectively. Expres-
sion from each of these plasmids
proved to be non-toxic to E. coli; a
typical growth curve following
induction of expression of 2C(34–
318) is shown in Fig. 1b. What is
more, these 2C proteins were all
expressed at a high level in the bac-
teria (typically 10 mg/liter culture)
and could be purified from the solu-
ble fraction of cell lysates (see
“Experimental Procedures”). After
processing with TEVpro, these 2C
proteins could be concentrated to
20 mg/ml (see “Experimental
Procedures”).
Interestingly, analyses by size
exclusion chromatography showed
that the apparent Mr of the larger
soluble 2C N-terminal deletion
mutants increased with the amount
of protein loaded, suggesting that
concentration-dependent subunit
association was occurring. The chro-
matographic profiles for each sample
contained a single asymmetric peak,
with a lagging slope on the low Mr
side of the peak, similar to the elution
profile shown for 2C(34–318) in Fig.
1c. They were very different from
the gel filtration chromatograms
obtained with MBP-2C from PV; in
particular, they did not contain any
high Mr aggregates in the void peak
(43). 2C(34–318) and 2C(38–318)
were found to form oligomers with
apparentMr valuesof up to about180
kDa. The oligomerization of 2C(52–
318) was less efficient, requiring
higher concentrations to give the
same yield of the largest species with
anapparentMr of180kDa(datanot
shown). In contrast, the shortest con-
struct, 2C(61–318), appeared to elute
at a maximum apparentMr of about
60 kDa (Fig. 1c) (see below). These
observations suggested that the
N-terminal amphipathic helix is not
required for oligomerization of
FMDV but nevertheless provided
an initial indication that residues
34–60 may contribute to oligomer stability. Because 20 mg/ml
solutions of 2C(38–318) displayed a weak tendency to aggre-
gate when warmed to room temperature, we opted to use the
slightly longer 2C(34–318) deletion mutant (which did not
exhibit this behavior) for further analysis of the enzymatic
properties of FMDV 2C.
FMDV 2C Is an ATPase—FMDV 2C contains Walker A,
Walker B, and C (or Sensor 1) motifs typical of SF3 helicases
FIGURE 2. FMDV 2C is a specific ATPase that is sensitive to NaCl and GdnHCl. The ATPase activity of FMDV
2C(34–318)wasmeasured in 100-l reactions containing 4gof protein (1.25M), 1mMATP, and 2mMMgCl2,
unless otherwise stated. a, ATP hydrolysis was measured in the presence of varying concentrations of protein
(open diamonds). Therewas no detectable ATPase activity for theWalker A, K116A (WA) (open circles), Walker B,
D160A (WB) (open triangles), and Motif C, N207A (MC) (crosses). The data plotted are an average of two exper-
iments. b, the ATPase activity is very sensitive to NaCl and decreases monotonically with an ED50 of about 10
mM. c, the ATPase activity of 2C(34–318) varies in a complex manner with increases in ATP concentration,
exhibiting a sharp decline between 1.25 and 1.5 mM substrate. d, comparative NTPase activity of 2C(34–318)
with 1 mM each ATP, GTP, CTP, and UTP. e, UV cross-linking of [-32P]ATP to FMDV 2C(34–318) and various
mutants (identified below each lane). After cross-linking, the protein sample was run on a 12% SDS-polyacryl-
amide gel. Top, the positions of protein bands were confirmed by staining with Coomassie Blue before gel
drying; bottom, cross-linked ATP was detected by exposure to a phosphor screen (bottom). 5 mM unlabeled
ADPor ATPwas included as indicated. f, effect of GdnHCl on theATPase activity ofwild-type FMDV2C(34–318)
(WT) (closed circles) and the 2C(34–318) M159L mutant (open circles). Error bars, S.E. determined from three
independent measurements.WA, Walker A;WB, Walker B;MC, motif C.
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and other AAA ATPases (Fig. 1a) (36) and, unsurprisingly,
was found to have goodATPase activity (Fig. 2a). To character-
ize this activity in greater detail, we examined the ability of
FMDV 2C(34–318) to hydrolyze ATP in a variety of different
conditions (Fig. 2 and supplemental Fig. S2). The ATPase
activity was optimal in the presence of 1–2 mM Mg2 (sup-
plemental Fig. S2a, closed circles) but was about 5 times less
efficient when the cation was replaced by Mn2 (supple-
mental Fig. S2a, open circles), similar to results obtained with
PV 2C (23). The activity was also maximal when the hydrolysis
reaction was performed at 32 °C (supplemental Fig. S2b) and
pH 7.4 (supplemental Fig. S2c), although the enzyme did not
display a very strong dependence on temperature or pH. In
contrast, the hydrolysis of ATP by FMDV 2Cwas very sensitive
to ionic strength; the catalytic reaction rate was reduced by 50%
in the presence of only 20 mM NaCl (Fig. 2b). The FMDV
enzyme is therefore more strongly affected by salt than PV 2C,
which was inhibited by 50% at 50 mM NaCl (23).
To examine the roles of each of the AAA ATPase motifs,
key residues in each were mutated. No ATP hydrolysis was
detected for 2C(34–318) proteins containing amino acid sub-
stitutions in theWalkerAmotif (K116A), in theWalker Bmotif
(D160A), or inMotif C (N207A) (Fig. 2a). These results suggest
that that each of the conserved AAA ATPase motifs are
involved in this activity. They also confirm that the ATP hydro-
lysis detected in our assays is a result of 2C(34–318) activity and
not due to an E. coli contaminant.
Interestingly, we observed that FMDV GST-2C had7-fold
higher ATPase activity than 2C(34–318) (Table 1). The ATP
hydrolysis rate of FMDV GST-2C was comparable with that
reported for similar fusions of PV 2C and for the homologous
murine norovirus protein, MNV p41 (Table 1) (23, 43, 58). The
precise reason for the increased activity of the GST-2C fusion
over the 2C(34–318) construct is not yet known. However, it is
possible that the retention of the full-lengthN terminus, even in
the context of a GST fusion, may stimulate the ATPase activity
of 2C.
FMDV 2C ATPase activity increased linearly from 0 to 1.25
mM ATP but then dropped by 30% at 1.5 mM and declined
slowly as theATP concentrationwas increased further (Fig. 2c).
The observed enzyme kinetics therefore differ significantly
from classical Michaelis-Menten behavior. For PV 2C, it was
necessary tomaintainMg2 concentrations at 1mM above that
of the ATP concentration to obtain a hyperbolic substrate
response curve from whichMichaelis-Menten kinetic parame-
ters could be derived (23). In the case of FMDV2C,maintaining
this elevated level of Mg2 failed to rescue the apparent inhibi-
tion at higher ATP concentrations. Nevertheless, based on the
half-maximal activity, an apparent value for theKm is estimated
to be 0.5 mM (similar to the Km of 0.7 mM found for PV 2C
(23)). FMDV2C is quite specific forATPbecause the hydrolysis
rates measured with GTP, CTP, and UTP substrates were at
least 10-fold lower than with ATP (Fig. 2d).
The binding of ATP to wild type andmutant 2C proteins was
analyzed byUVcross-linking.Weobserved efficient cross-link-
ing ofATP towild type 2C(34–318), consistentwith good bind-
ing of the substrate (Fig. 2e, lane 3). The addition of 5 mM
unlabeled ATP or ADP reduced the cross-linking of radiola-
beled ATP to 2C(34–318) to background levels (lanes 8 and 9),
confirming the specificity of the interaction detected in this
experiment. Both the Walker A (K116A) (lane 5) and the
Walker Bmutant (D160A) (lane 6) mutants of 2C(34–318) dis-
played very low levels of cross-linking, comparable with the
signal obtained with a control protein (FMDV 3C protease),
which does not bind ATP (lane 3). In marked contrast, intro-
duction of an N207A mutation within Motif C caused only a
very modest decrease in UV cross-linking to FMDV 2C(34–
318) (lane 7), suggesting that the ability to bind ATP is retained
in this mutant.
GdnHClHas Stimulatory and Inhibitory Effects on FMDV2C
ATP Hydrolysis—FMDV infections are sensitive to millimolar
concentrations of GdnHCl (29, 59). For example, the addition
of 3 mM GdnHCl led to a greater than 16-fold reduction in
FMDV RNA synthesis in infected cells (29). In common with
other picornaviruses, the drug seems to target 2C because
mutations that confer resistance toGdnHCl have beenmapped
to this protein (29, 60). We found that purified FMDV 2C(34–
318) was inhibited byGdnHCl but only atmuch higher concen-
trations than affect virus replication (Fig. 2f, closed circles). Sur-
prisingly, at low millimolar concentrations of GdnHCl (1–5
mM) that are inhibitory to virus infection, there is an increase in
2C(34–318) ATPase activity of up to 30%. Above 5 mM, the
drug starts to inhibit the enzyme; by 10mMGdnHCl, the rate of
ATP hydrolysis has returned to that observed in the absence of
the drug, and at 20mMGdnHCl, the activity is reduced by about
55%. Complete inhibition is observed at drug concentrations
above 60 mM.
The M159L mutation in FMDV 2C that renders the virus
resistant to GdnHCl (29) was inserted into 2C(34–318).
Despite the conservative nature of the amino acid substitution,
the mutant protein was significantly less soluble than wild type
2C and could only be concentrated to 1.5mg/ml. In the absence
of GdnHCl, the ATPase activity of the 2C(34–318) M159L
mutant was only 25% of wild type (Fig. 2f, open circles). The
response of thismutant enzyme to increasing concentrations of
GdnHCl was quite different from the behavior exhibited by
wild-type 2C. There was no significant stimulation of ATPase
activity at low concentrations of GdnHCl, and the enzyme was
less sensitive to inhibition by the drug, requiring35 mM to be
inhibited 50% compared with an ED50 of 18 mM observed with
the wild-type protein (supplemental Fig. S2d). These results are
consistent with the observed effect of the M159L mutation in
TABLE 1
ATPase activity of FMDV deletion and active site mutants
Construct ATPase activity Source/Reference
pmol Pi/pmol
protein/min
GST-FMDV 2C 17 This report
GST-PV 2C 13.3a Ref. 23
GST-MNV p41 17.3a Ref. 58
FMDV 2C(34–318) 2.3 This report
FMDV 2C(34–318) K116A (Walker A) 0.017 This report
FMDV 2C(34–318) D160A (Walker B) 0.017 This report
FMDV 2C(34–318) N207A (Motif C) 0.042 This report
FMDV 2C(61–318) 0.46 This report
a The values reported in the associated references were converted to these units for
comparison.
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infected cells (29), although there are obvious discrepancies in
the sensitivities of 2C and the virus to the presence of the drug.
ATP binding in the presence of varying concentrations of
GdnHCl was also analyzed by UV cross-linking. As shown in
supplemental Fig. S3a (solid line), there is a slight increase in
ATP cross-linking in the presence of low concentrations of
GdnHCl, suggesting that low levels of the drug may act by
enhancing affinity for the ATP substrate. In the presence of 40
mM GdnHCl, a concentration of the drug that inhibits ATPase
activity by about 50% (Fig. 2f), UV cross-linking of ATP is as
strong as that observed in the absence of the drug (sup-
plemental Fig. S3a). The differential effects of GdnHCl, at low
and high concentrations, on the binding and hydrolysis of ATP
by 2C(34–318) appear to indicate dual modes of interaction
between the protein and the drug.
We also examined whether increases in ionic strength pro-
duce their marked inhibitory effect on ATPase activity by
reducing binding of ATP to FMDV 2C. Increasing the NaCl
concentration clearly decreased UV cross-linking of ATP
(supplemental Fig. S3b). In fact, the dose dependence of the
decrease in UV cross-linking in the presence of NaCl follows a
similar trend to the observed reduction in ATPase activity
(supplemental Fig. S3b). These results suggest that, in contrast
to GdnHCl, NaCl inhibits the enzyme by reducing binding of
the ATP substrate.
FMDV 2C Binds ssRNA—As mentioned in the Introduction,
previous experiments to examine the RNA binding proper-
ties of picornavirus 2C proteins may have been hampered
by the poor solubility and nonspecific aggregation of the
recombinant proteins used (17, 32, 34, 61). In our experi-
ments, FMDV 2C(34–318) was purified as a soluble protein
without denaturation, and elec-
trophoretic mobility shift assay
experiments were performed
under native conditions. We
observed that increasing concentra-
tions of 2C(34–318) formed a single,
well defined slower migrating com-
plex with a randomly selected 20-
base ssRNA oligomer (5-AAU-
UCUAAGGGCCAGCGAGA) (Fig.
3a). 2C(34–318) bound the 20-base-
long ssRNA with an apparent Kd of
5 M under our experimental
conditions (estimated as the con-
centration needed to bind 50% of
the RNA and taking no account of
possible oligomerization of 2C).
The interaction between RNA and
FMDV 2C was dependent on the
length of the RNA. 2C(34–318)
bound 12 and 20 nucleotide RNAs
(Fig. 3a and supplemental Fig.
S4b) with similar affinity, but
binding to RNAs that were 7 or 10
nucleotides long was significantly
weaker (apparent KD  40 M)
(Fig. 3b and supplemental Fig.
S4a). Notably, 2C(34–318) had a much higher affinity for
ssRNA over blunt-ended dsRNA of the same length (20 bp),
which was bound with an apparentKD of over 60M (Fig. 3c).
Although the biological function of 2C is unknown, its simi-
larity to the SF3 helicase family of proteins has prompted sug-
gestions that it may have a role in unwinding dsRNA (19). The
ATPase activity of other hexameric helicases, such as BPV E1
and gene 4 protein of T7 bacteriophage, is observed to be stim-
ulated in the presence of a DNA substrate (46, 62). However,
the addition of asmuch as a 100-foldmolar excess of the 20-nu-
cleotide ssRNA oligomer used in the electrophoretic mobility
shift assays had no effect on the ATPase activity of 2C(34–318)
(Fig. 3d).
RNA and ATP Binding Stabilize Hexameric Form of FMDV
2C—Inmost cases, AAA proteins form hexameric rings, with
the ATPase active site at the interface between neighboring
subunits (39, 57). An MBP fusion of PV 2C was recently
reported to form homo-oligomeric structures required for the
ATPase activity of the protein (43); in this case, a mixed popu-
lation of oligomeric states ranging from tetramers to octamers
was observed, but it was not clear if all of these represent func-
tional assemblies.
As noted above, FMDV 2C(34–318), which is soluble to at
least 20 mg/ml, was found to exhibit concentration-dependent
oligomerization during SEC (Fig. 1c). Increasing the loading of
purified protein samples ranging from 5 to 20 mg/ml onto the
SEC column progressively reduced the elution volume, indicat-
ing the formation of highermolecularmass species (Fig. 1c) that
appeared to attain a maximum value of about 180 kDa when
compared with the elution position of molecular mass stan-
dards. Since the calculated molecular mass for 2C(34–318) is
FIGURE 3. FMDV 2C binds to ssRNA with higher affinity than to dsRNA. The binding of 2C(34–318) to
32P-5-end-labeled RNA was measured in electrophoretic mobility shift assays (see “Experimental Proce-
dures”). Protein-RNAcomplexeswere resolvedonanative 10%polyacrylamidegel,whichwas thenexposed to
a phosphor screen. The positions of the free unbound probe (Free) and protein-RNA complex (Com) are indi-
cated. Varying concentrations of 2C(34–318) (2C) were added to labeled 20-base ssRNA (5-AAUUCUAAGGGC-
CAGCGAGA-3) (a) or labeled 10-base ssRNA (5-CCUUAGAAUU-3) (b). c, a dsRNA probe (DS) was prepared by
mixing the 20-base-long probe from awith an unlabeled complementary RNA of exactly the same length, at a
molar ratio of 1:1.2, heating to70 °C for 5min, and cooling to22 °Cover 2h.d, theATPase activity of 2C(34–318)
was measured in the presence of various amounts of single-stranded RNA. Error bars, S.E. determined from
three independent measurements.
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32 kDa, these data were initially interpreted to indicate the for-
mation of hexamers of 2C, consistent with the oligomerization
behavior of members of the SF3 helicase/AAA ATPase
superfamily.
To provide a more precise examination of 2C(34–318) olig-
omerization, we used SEC-MALS, which permits absolute Mr
determination of macromolecules (63). For a sample loading of
0.5 ml at 20 mg/ml (equal to the highest concentration used in
the SEC experiment shown in Fig. 1c), fitting of the light scat-
tering data revealed a distribution of molar mass indicative of
concentration-dependent oligomerization of 2C(34–318) with
the maximum observed mass corresponding to a tetrameric
species (Fig. 4a, solid line). There
was no evidence to indicate the
presence of hexamers under these
conditions. This result shows that
the initial SEC analysis had signifi-
cantly overestimated the Mr of
2C(34–318) oligomers, perhaps due
to aberrant retention of the protein
on the column. In contrast, the larg-
est oligomeric species identified by
SEC-MALS for 2C(61–318) was
60 kDa (Fig. 4b, solid line), con-
sistent with previous SEC measure-
ments that suggested that this form
of the protein cannot assemble into
oligomeric states larger than
dimers. These results suggest that
residues in the region 34–61 of
FMDV2C are involved in stabiliza-
tion of higher order oligomers of
2C, probably by mediating inter-
actions between subunits.
Because 2C(34–318) was found
to bind both ATP and ssRNA (Figs.
2 and 3), the effects of these ligands
on oligomerization were investi-
gated, first with SEC and subse-
quently with SEC-MALS. In these
experiments, a 0.5-mg loading (100
l at 5 mg/ml) was used to ensure
that unliganded 2C(34–318) was in
the monomeric form so that the
assay would provide a sensitive mea-
sure of any enhancement of olig-
omerization due to ligand binding.
When added, ATP was maintained
at 2 mM in the running buffer in
these experiments to counteract
dissociation during the chromato-
graphic run. As shown in Fig. 4c
(solid line), at this low protein con-
centration, 2C(34–318) eluted from
the SEC column with an estimated
Mr of 30 kDa, which is consistent
with it being monomeric. The posi-
tion of the peak was not affected by
the addition of ATP (dotted line). It is shifted slightly in the
presence of RNA (dashed line). This shift may be due to the
effect of RNA on the interaction of 2C(34–314) with the col-
umn matrix. In the presence of both ATP and RNA, the peak
profile appeared as a mixture of the ATP-bound and RNA-
bound forms, but therewas no indication of hexamer formation
(dashed and dotted line).
The effect of ATP and ssRNA on the 2C(34–318) Motif C
mutant, N207A, was then tested by SEC because this mutant
binds but does not hydrolyze ATP (Fig. 4d). This gave elution
profiles that were broadly similar to wild-type 2C(34–318) in
the presence of either ATP or ssRNA (data not shown). How-
FIGURE 4. ATP and RNA stimulate the hexamerization of FMDV 2C. Oligomerization of 2C(34–318) and
2C(61–318) was analyzed by SEC and SEC-MALS. 10mg of 2C(34–318) (a) or 2C(61–318) (b) was loaded onto a
Superdex S200 10/30 column coupled to in-line light scattering and refractive index detectors. The refractive
indexmeasurement (dotted line) indicates the concentration of protein in the eluate. Themolecular weight of
the protein species in the eluate (determined from the refractive index and light scattering measurements)
(63)) is indicated by the solid line. c–f, 100l of 5mg/ml wild type ormutant 2C(34–318) or 2C(61–318) protein
weremixedwith 2mMATPorADP, 5mMMgCl2, and a 5-foldmolar excess of 20-nucleotide ssRNA (as indicated)
and incubated for 10minat 22 °Cprior to injectionontoaSuperdexS20010/30 column for analysis by standard
SEC (c and d) or SEC-MALS (e and f). The arrow in c indicates the sample used for electronmicroscopywork (see
Fig. 5).
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ever, when bothATP and ssRNAweremixedwith 2C(34–318),
N207A, a well defined species with high molecular weight was
detected (Fig. 4d, solid line). Notably, this peak was not
observed upon the addition of ADP and ssRNA, indicating that
the intact nucleotide triphosphate is necessary for the observed
oligomerization (Fig. 4d, dashed line). Consistent with this
interpretation, the 2C(34–318) K116A Walker A mutant,
which does not hydrolyze or bind ATP (Fig. 2, a and e), was
unable to form high molecular weight complexes in the pres-
ence of ssRNA and ATP (Fig. 4d, dotted line).
Determination of Mr using SEC-MALS revealed that the
Motif C N207A mutant of 2C(34–318) forms hexamers upon
the addition of ligands. As shown in Fig. 4e (solid line), the
molecular mass of the 2C(34–318) N207A oligomer obtained
in the presence of ATP and ssRNA is 182 kDa, consistent with
hexamerization of the protein.
Strikingly, although the largest oligomeric species of 2C(61–
318) detected in the absence of ligand was dimeric (Fig. 4b),
SEC-MALS analysis showed that ssRNA and ATP also stabi-
lized hexamers of 2C(61–318) N207A (Fig. 4f, solid line). The
stabilization of hexamers was less efficient for the 2C(61–318)
mutant than for the 2C(34–318) mutant, as shown by the rela-
tive areas of the peaks corresponding to the hexameric species
and monomer/dimer species in each case (Fig. 4, e and f). The
decreased propensity of 2C(61–318) to oligomerize is accom-
panied by a proportional impairment of ATPase activity; this
enzyme hydrolyzes ATP 5 times less efficiently than the longer
2C(34–318) (Table 1). 2C(61–318) nevertheless appears to
bind ATP as strongly as 2C(34–318), as shown in UV cross-
linking experiments (Fig. 2e). These results are consistent with
the idea that the reduced ATPase activity results from de-
creased oligomerization (although a more direct effect of resi-
dues 34–61 on ATPase activity cannot be ruled out).
FMDV2CFormsHexameric Ring Structures Characteristic of
AAA ATPases—The detection of stable oligomerization of
the 2C(34–318)N207AMotif Cmutant in the presence of ATP
and RNA allowed us to analyze the complex by negative stain
electronmicroscopy. A sample of the stabilized hexameric spe-
cies, at a concentration of 1 M, was taken directly from the
hexameric peak in an SEC experiment and negatively stained
with uranyl acetate within 30 min (see “Experimental Proce-
dures”). Examination of micrographs revealed the presence of
small ringlike structures with diameter of about 140 Å (Fig. 5a).
The majority of the particles appeared to be aligned so that the
plane of the ring of the 2C oligomers was parallel to the plane of
the micrograph, suggesting that the 2C oligomers adopt a pre-
ferred orientation on the grid. Because of the relatively small
size of FMDV 2C, it is possible that only this view of the oligo-
meric form of the protein is distinct enough to be clearly
observed using electronmicroscopy. Alternatively, the fixing of
the protein on the grid before staining may also have led to
preferential views of the complex. A total of 1600 particles were
picked to assemble a data set for further analysis of the popula-
tion of 2C complexes (Fig. 5b).
To identify symmetry components in the data set, the images
of the 2C(34–318)-ATP-RNA complexes were translationally
aligned to a rotational average of the entire data set using the
method of Dube et al. (55). MSA followed by classification was
performed on the final data set, and class averages were gener-
ated, many of which displayed clear hexamerization of FMDV
2C (Fig. 5c). The eigenimages from the initial MSA, which
describe the interimage variance, also indicate a clear 6-fold
FIGURE5.TheMotifCmutantofFMDV2C(34–318) formshexameric rings
in thepresenceofATPandRNA.Asampleof the2C(34–318)Motif Cmutant
(N207A) hexamers obtained in thepresenceofATP andRNA (indicatedby the
arrow in Fig. 4c) was applied to glow-discharged carbon grids and negatively
stained with uranyl acetate. Electron micrographs were taken on a Philips
CM200 electron microscope operating at 200,000 V under low dose condi-
tions of 10 e/Å2. Images were captured directly at 50,000 times magnifica-
tion over a range of nominal defocus (0.5–2 m) on a CCD camera. a, a rep-
resentativemicrograph of FMDV 2C particles (indicated by arrows). Scale bar,
200 Å. b, a selection of FMDV 2C particles following initial processing by
IMAGIC (54). Scale bar, 100 Å. c, a range of hexameric FMDV 2C class averages
(20 particles/class). Scale bar, 100 Å. d, left to right, first, second, third, and
fourth eigenimages reveal the 6-fold symmetry in the FMDV 2C data set.
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symmetry (Fig. 5d). The diameter of the FMDV 2C rings
observed in the class averages is 140 Å, consistent with the
dimensions of E1 (97 Å) and LTag (128 Å) SF3 helicase hexa-
mers (39, 40), which have similarly sized ATPase domains. Our
electron microscopy and SEC-MALS data demonstrate for the
first time that FMDV 2C can form stable hexamers upon bind-
ing of ATP and RNA.
Consistent with the absence of a hexameric peak for wild-
type 2C(34–318) in the presence of ATP and RNA in gel filtra-
tion experiments, no ringlike structures of FMDV 2C were
observed inmicrographs taken fromnegatively stained samples
prepared bymixing the protein with these two ligands (data not
shown).
FMDV 2C Hydrolyzes ATP through a Coordinated Mecha-
nism—Themechanism of ATP hydrolysis in AAA hexameric
rings has been studied in a number of systems. For example,
ClpX, a protein-unfolding AAA ATPase, was reported to
hydrolyze ATP in an uncoordinated manner (64) (hydrolysis
occurs randomly at any site), whereas SV40 LTag (65) and BPV
E1 (39) helicases were both found to hydrolyze ATP through
coordinated mechanisms (hydrolysis occurs at multiple sites
simultaneously or with rotational synchronization around the
ring). Toprobe themechanismofATPhydrolysis by FMDV2C,
subunit-mixing experiments were performed. Wild type
2C(34–318) subunits were mixed with the K116A Walker A
mutant in molar ratios ranging from 6:0 to 0:6 and assayed for
ATPase activity. For an uncoordinatedmechanism, theATPase
activity would be expected to decrease linearly as the ratio of
inactive to active 2C subunits was increased. Instead, the
ATPase activity decreased non-linearly (Fig. 6a); a sharp
decline in activity of 50–60% was observed when only one-
sixth of the subunits were catalytically inactive. This result
clearly indicates that hydrolysis by 2C is coordinated around
the subunits in the ring. A similar experiment performed with
the 2C(61–318) protein showed the same non-linear decrease
in ATPase activity upon mixing with 2C(61–318) K116A (Fig.
6b), suggesting that the ATPase activity detected from 2C(61–
318) also results from the transient formation of hexamers that
are needed to coordinate ATP hydrolysis. This is consistent
with the detection by SEC-MALSof hexamers of 2C(61–318) in
the presence of ATP and ssRNA (Fig. 4e).
The results of our subunit-mixing experiments with FMDV
2C are consistent with the dominant negative effects observed
on co-expression of active and inactive subunits of PVMBP-2C
(43).
DISCUSSION
Expression of FMDV 2C—Most previous characterizations of
picornaviral 2C proteins have been performed using recombi-
nant N-terminal fusions to GST or MBP without removing the
large protein tag because this generally resulted in loss of the
protein through aggregation (23–26). The ability of these par-
ticular fusion partners to increase the solubility of different pro-
teins is well documented (66–70). In the case of 2C, such large
tags may aid solublization by sterically blocking the hydro-
phobic interactions made by the conserved N-terminal
amphipathic helix. Although these reagents have facilitated
analyses of the enzymatic and RNA binding activities of the
protein, the use of large proteinaceous tags does not completely
resolve the solubility of 2C proteins because the tags cannot be
removed without resulting in significant loss of protein (43); in
at least one case, proteolytic processing failed to efficiently
remove the tag, which is suggestive of misfolding (24). More-
over, even when the tag is retained, there is evidence of residual
aggregation (43) and difficulties with purification (23).
In the present study, we adopted a different approach.
Although fusion of GST to theN terminus of full-length FMDV
2C facilitated the expression in E. coli, the resulting protein was
poorly soluble. Expression of soluble FMDV 2C protein with a
short N-terminal His6 tag was only possible after genetic dele-
tion of the predictedN-terminal amphipathic region of the pro-
tein was found to eliminate its toxicity in E. coli. This result is
consistent with the boost in solubility observed due to deletion
of the first 21 amino acids ofHAV2C,whichwould be expected
to remove most of the predicted amphipathic helix (14, 17).
However, in that case, no quantitative assessments of yield or
protein solubility were made. The largest FMDV 2C protein
obtained by this deletion approach in the present study yielded
2C(34–318), which, following proteolytic removal of the His6
tag, remained highly soluble and could be concentrated to at
least 20 mg/ml. The reason for the toxic effects of retaining the
N-terminal amphipathic helix of 2C are not known, although it
seems likely to be related to the membrane-binding properties
attributed to this part of the protein in studies of 2C from PV
FIGURE 6.ATPhydrolysis by FMDV2C is coordinated. a, various ratios ofwild
type 2C(34–318) (WT) and 2C(34–318) Walker A mutant, K116A (MUT), were
mixed before addition to an ATPase assay. b, various ratios of wild type 2C(61–
318) and 2C(61–318)Walker Amutant, K116A,weremixedbefore addition to an
ATPase assay. Asynchronous ATP hydrolysis would be expected to decrease lin-
early as the amount of inactive enzyme is increased (dotted line in both plots).
Data are averages of three experiments S.E. (error bars).
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(15, 16) and HAV (17). Although this approach produces an
N-terminally truncated 2C protein, it retained ATPase, RNA
binding, and oligomerization activities that could be analyzed
in detail within in vitro experiments. Given the high level of
sequence identity between picornavirus 2C proteins, we believe
that similar N-terminal deletions should facilitate the produc-
tion of soluble 2C proteins in E. coli. However, the method is
not foolproof; we were able to clone and express similar soluble
deletion mutants of 2C from type C FMDV but not 2C from
swine vesicular disease virus.6
FMDV 2CHas ATPase Activity—Unsurprisingly, each of the
WalkerA andBmotifs andMotif Cwas found to be required for
the ATPase activity of FMDV 2C (Fig. 2a). The side chains of
Lys116 and Asp160 in the Walker A and B motifs, respectively,
appear to be important for ATP binding because mutation to
Ala decreased UV cross-linking of the nucleotide to back-
ground levels. Interestingly, this pattern of binding differs from
that recently reported for PV 2C (43); the D177A Walker B
mutation in MBP-PV 2C (equivalent to D160A in FMDV 2C)
had no effect on ATP cross-linking, whereas the K135A muta-
tion (equivalent to K116A) was found to greatly reduce ATP
cross-linking to the protein. The reason for the different effects
of mutating the conserved Asp residue in theWalker Bmotif of
the 2C proteins from the two viruses is not clear. The ATP
hydrolysis sites of PV 2C and FMDV 2C would be expected to
be quite similar because the regions thought to form the active
sites are well conserved (62% identical across A, B, and C) (19).
However, it is notable that the ATPase activities of 2C proteins
from PV and FMDV respond quite differently to GdnHCl,
which may also be due to structural differences at or near the
ATP binding site; FMDV 2C is stimulated by low concentra-
tions of the drug and only inhibited at about 20 mM (Fig. 2f),
whereas PV 2C exhibits monotonic inhibition with an ED50 of
about 2 mM (23). A further indication of possible structural
differences at the ATP binding site comes from the observation
that the M159L mutation that confers FMDV resistance to
GdnHCl (29) is inside the Walker B motif, whereas the
N179G/A mutations that confer GdnHCl resistance on the
virus and rescue PV 2C ATPase activity are just outside its
Walker B motif (Val172–Asp177) (23).
The clustering of mutations that confer resistance to
GdnHCl around the ATPase active site of 2C from different
picornaviruses suggests that the drug may bind close to the
nucleotide binding site (23, 29). Although it was misassigned as
“non-competitive,” the detailed kinetic analysis by Pfister and
Wimmer revealed that GdnHCl is actually an uncompetitive
inhibitor of PV 2C (see Fig. 7b of Ref. 23), whichmeans that the
drug only binds to inhibit in the presence of ATP. This obser-
vation is consistent with the results of UV cross-linking exper-
iments with FMDV 2C, which showed that GdnHCl does not
reduce ATP binding at concentrations known to inhibit its
ATPase activity (supplemental Fig. S3). However, although the
inhibition of the ATPase activity of PV 2C by submillimolar
concentrations of GdnHCl appears to fully account for the
block of PV infectivity by this drug (23), the ATPase activity of
purified 2C from FMDV is about an order of magnitude less
sensitive to GdnHCl than the virus infectivity (Fig. 2) (23, 29), a
pattern of response that is similar to that observed with EV9
(28) (although, like PV, EV9 is an enterovirus). This relative
insensitivity of 2C from FMDV and EV9 to inhibition by
GdnHCl remains unexplained; it may be that 2BC is a more
sensitive target for the drug or that it acts on additional targets
in these viruses.
RNA Binding by FMDV 2C—We found that FMDV 2C(34–
318) binds short ssRNA in a non-sequence-specific manner,
with at least a 10-fold higher affinity than it bound to a ran-
domly selected dsRNA (Fig. 3). Similarly, EV9 2C was reported
to bind single-stranded RNA nonspecifically but with a prefer-
ence for unstructured RNAs (34). If 2C indeed functions as an
RNA helicase, it would be expected to interact with RNA in a
sequence-independent manner, although the possibility that
2C can interact with RNA in other ways (perhaps to fulfill a
different role during replication) cannot be discounted. It
should be noted that PV 2C has been reported to bind in
a sequence-specific manner to the 3-end of the viral negative
strand RNA, which is predicted to adopt a cruciform stem loop
structure (33, 71), an observation that has been repeated with
2C from HAV and human rhinovirus (32). FMDV is not pre-
dicted to contain a similar structure at the 3-end of its negative
strand RNA, and further work will be necessary to determine if
FMDV 2C also possesses specific RNA binding.
ATP and RNA Binding Stimulate Hexamerization of FMDV
2C—An N-terminal MBP fusion of PV 2C was recently shown
to form homo-oligomeric structures necessary for ATPase
activity (43). Negative stain and scanning electron microscopy
were used to examine the structure of PV 2C oligomers and to
determine the stoichiometry of their assembly. This latter anal-
ysis, which was aided by the retention of the MBP tags that
appeared as distinct lobes of density surrounding the core of the
oligomer, revealed the presence of mixed populations of oligo-
meric states of the fusion protein ranging from tetramer to
octamer (43).
Oligomerization of recombinant FMDV 2C(34–318) oc-
curred in a concentration-dependentmanner; in the absence of
ligand, the largest oligomeric state detectable was tetrameric
(Figs. 1c and 4). This result is broadly similar to findings with
other SF3 proteins; in the presence of DNA but not ATP, the
largest assembly of LTag observed is tetrameric (72), whereas
intermediate oligomeric assemblies were also identified for E1
(73). However, in contrast to the LTag and E1 helicases, which
both form stable hexamers in the presence of ATP (40, 74), the
addition of the nucleotide failed to stabilize FMDV2C(34–318)
hexamers (Fig. 4c). Instead, we found that both ATP and RNA
are required to observe stable hexamers of FMDV 2C(34–318)
and that this can only be achieved if the protein incorporates
the Motif C mutation N207A, which abrogates ATP hydrolysis
but does not significantly impair binding of the nucleotide.
Strikingly, in contrast to MBP-PV 2C, this ternary 2C-ATP-
RNAcomplex forms a single oligomeric specieswith six protein
subunits (Fig. 4). The stabilization due to ATP probably arises
because its binding site is predicted to occur at the interface
between pairs of subunits in the hexameric ring; moreover, by
analogy with the co-crystal structure of the BPV E1-ATP/ADP-6 T. R. Sweeney and S. Curry, unpublished data.
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DNAcomplex (39), the RNAmay contribute to hexamerization
by binding to the pore through the center of the hexamer and
making contacts with all six subunits. Although we have not
observed hexamerization of wild-type 2C(34–318), due pre-
sumably to its ATPase activity, it should be noted that absence
of the authentic N terminus may also have impaired subunit
interactions (see below). Further work will be needed to exam-
ine the oligomerization behavior of full-length FMDV 2C and
to determine the structure of the hexameric FMDV 2C-ATP-
RNA complex.
It is difficult to precisely compare the results obtained using
FMDV2C(34–318) with those obtained using PVMBP-2C due
to gross structural differences between the two proteins and
differences in experimental approaches; for example, the
effects of ATP and RNA on the oligomerization behavior of PV
MBP-2C were not analyzed (43). Nevertheless we believe there
is at least suggestive evidence that the two proteins have impor-
tant properties in common. In the absence of ligands, both pro-
teins formed a range of oligomers of a range of sizes, ranging
fromone to four subunits for FMDV2C(34–318) and from four
to eight subunits for PV MBP-2C. We suspect that the larger
size range of PV MBP-2C particles may be partly due to the
residual aggregation of this protein (as indicated by the signifi-
cant void peak observed by SEC analysis), but there may also be
contributions from the Cys-rich motif in the C terminus of PV
2C that is absent in the FMDV protein. It is also notable that
hexamers were the most commonly observed form of PV
MBP-2C (43). Given the homology between picornavirus 2C
proteins and the observation that many other AAA proteins
are observed to function as hexamers, we propose that the hex-
americ rings observed for FMDV 2C(34–318) are the most
physiologically relevant form of picornavirus 2C proteins. This
hypothesis is supported by the finding that FMDV 2C hydro-
lyzes ATP by a coordinated mechanism (Fig. 6), which is likely
to involve subunit-subunit interactions.
We suspect that the observations of the effects of N-terminal
modifications on oligomerization of FMDV and PV 2C support
a commonmode of assembly although they superficially appear
to be at odds with one another. When examined within the
context of an MBP fusion protein, removal of the first 38 resi-
dues from the N terminus of PV 2C was found to completely
abrogate the ability of the protein to oligomerize and to hydro-
lyze ATP (43). The authors therefore concluded that the N ter-
minus of PV 2C was necessary for oligomerization. Strikingly,
the MPB-PV 2C(39–329) used in these experiments lacks all
residues up to and including the predicted N-terminal
amphipathic helix (residues 20–36 (14)) and therefore contains
a very similar deletion to the FMDV 2C(34–318) Motif C
mutant that was shown to hexamerize in the present study.
What is the source of this discrepancy? Significantly, the inves-
tigation of PV2Coligomerizationwas performedwithMBP-2C
constructs in whichMBP remained attached to theN terminus.
We suggest that deletion of the N terminus of 2C within such a
construct may have brought the MBP domain close enough to
the body of the ATPase domain of PV 2C to interfere sterically
with the subunit-subunit contacts needed for oligomerization
and ATPase activity. Consistent with this idea, there is no tag
in FMDV 2C(34–318) to interfere with the formation of
hexamers.
Our results show that the first 33 amino acids of FMDV 2C,
including the predicted amphipathic helix, are not required for
hexamerization, at least in the presence of ATP and ssRNA.
However, it is still possible that the presence of the N terminus
of the protein may further stabilize the hexameric form of the
enzyme; for example, the predicted amphipathic helixmay con-
tribute to interactions between subunits ormay help to concen-
trate 2C subunits on the two-dimensional surfaces on internal
cellular membranes.
We did find clear evidence that the N-terminal residues of
the FMDV 2C(34–318) truncation mutant are important for
higher order oligomerization because 2C(61–318) was signifi-
cantly less efficient at assembling into hexamers (Fig. 4e).
Intriguingly, both the LTag andE1helicases possess smallmod-
ules of about 50 amino acids on the N-terminal side of their
ATPase domains that are reported to facilitate hexamerization
(40, 74). Structural analyses have shown that these N-terminal
modules fold into small helical domains (containing 4–5 -
helices) that associate with one another into a second hexa-
meric ring structure above the ring formed by the ATPase
domains (39–41). However, there is no amino acid sequence
homology between these N-terminal domains and the segment
at theN terminus of 2C(34–318) that aids hexamerization (res-
idues 34–60). The structural basis for the ability of residues
34–60 to stabilize hexamers of FMDV 2C therefore remains to
be determined.
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